Free Trial
NASDAQ:CALC

CalciMedica (CALC) Stock Price, News & Analysis

CalciMedica logo
$1.62 +0.04 (+2.47%)
As of 07/3/2025 02:21 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About CalciMedica Stock (NASDAQ:CALC)

Key Stats

Today's Range
$1.60
$1.65
50-Day Range
$1.43
$2.06
52-Week Range
$1.42
$5.97
Volume
21,507 shs
Average Volume
42,028 shs
Market Capitalization
$22.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.00
Consensus Rating
Buy

Company Overview

CalciMedica Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

CALC MarketRank™: 

CalciMedica scored higher than 62% of companies evaluated by MarketBeat, and ranked 345th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CalciMedica has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    CalciMedica has only been the subject of 1 research reports in the past 90 days.

  • Read more about CalciMedica's stock forecast and price target.
  • Earnings Growth

    Earnings for CalciMedica are expected to decrease in the coming year, from ($2.21) to ($2.24) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CalciMedica is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CalciMedica is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    CalciMedica has a P/B Ratio of 1.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about CalciMedica's valuation and earnings.
  • Percentage of Shares Shorted

    1.73% of the float of CalciMedica has been sold short.
  • Short Interest Ratio / Days to Cover

    CalciMedica has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CalciMedica has recently decreased by 2.48%, indicating that investor sentiment is improving.
  • Dividend Yield

    CalciMedica does not currently pay a dividend.

  • Dividend Growth

    CalciMedica does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.73% of the float of CalciMedica has been sold short.
  • Short Interest Ratio / Days to Cover

    CalciMedica has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CalciMedica has recently decreased by 2.48%, indicating that investor sentiment is improving.
  • News Sentiment

    CalciMedica has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for CalciMedica this week, compared to 1 article on an average week.
  • Search Interest

    2 people have searched for CALC on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CalciMedica insiders have bought more of their company's stock than they have sold. Specifically, they have bought $20,580.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    41.55% of the stock of CalciMedica is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about CalciMedica's insider trading history.
Receive CALC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CalciMedica and its competitors with MarketBeat's FREE daily newsletter.

CALC Stock News Headlines

Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
See More Headlines

CALC Stock Analysis - Frequently Asked Questions

CalciMedica's stock was trading at $3.54 at the beginning of the year. Since then, CALC shares have decreased by 54.3% and is now trading at $1.6190.

CalciMedica Inc. (NASDAQ:CALC) issued its quarterly earnings results on Wednesday, May, 14th. The company reported ($0.36) EPS for the quarter, topping the consensus estimate of ($0.43) by $0.07.

Shares of CALC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CalciMedica investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), AST SpaceMobile (ASTS), NIO (NIO), Bakkt (BKKT) and Castor Maritime (CTRM).

Company Calendar

Last Earnings
5/14/2025
Today
7/06/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CALC
Fax
N/A
Employees
30
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$18.00
High Stock Price Target
$20.00
Low Stock Price Target
$16.00
Potential Upside/Downside
+1,011.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$13.70 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.07 per share
Price / Book
1.51

Miscellaneous

Free Float
8,167,000
Market Cap
$22.62 million
Optionable
No Data
Beta
1.24
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:CALC) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners